Bioresorbable Scaffold Technologies
スポンサーリンク
概要
- 論文の詳細を見る
Fully bioabsorbable scaffolds (BRS) are a novel approach that provides transient vessel support with drug delivery capability without the long-term limitations of the metallic drug-eluting stents (DES), such as permanent caging with or without malapposition. The technology has the potential to overcome many of the safety concerns associated with metallic DES, and possibly even convey further clinical benefit. Although the technology is still in its infancy, several devices have been tested in clinical trials and the initial results have been very promising. This review will discuss the emerging need for BRS, the theoretical advantages of this new technology over current generation metallic DES and review the status of the currently available BRS. In addition, we will discuss the ideal duration of bioresorption, the proven and potential clinical benefits and future perspectives of this rapidly progressing technology. (Circ J 2011; 75: 509-520)
著者
-
ORMISTON John
Auckland City Hospital
-
Onuma Yosinobu
Thoraxcenter, Erasmus Medical Center
-
Serruys Patrick
Thoraxcenter, Erasmus Medical Center
関連論文
- Short- and Mid-Term Intravascular Ultrasound Analysis of the New Zotarolimus-Eluting Stent With Durable Polymer : Results From the RESOLUTE Trial
- Bioresorbable Scaffold Technologies
- Comparison of Vascular Response to Zotarolimus-Eluting Stent vs Paclitaxel-Eluting Stent Implantation : Pooled IVUS Results From the ZoMaxx I and II Trials
- Coronary Stent Implantation in a Septal Perforator Artery : Case Report and Review of the Literature
- Bioresorbable Scaffold Technologies
- Vascular Compliance Changes of the Coronary Vessel Wall After Bioresorbable Vascular Scaffold Implantation in the Treated and Adjacent Segments